Cargando…
Cost Analysis of Screening for, Diagnosing, and Staging Prostate Cancer Based on a Systematic Review of Published Studies
INTRODUCTION: The reported estimates of the economic costs associated with prostate cancer screening, diagnostic testing, and clinical staging are substantial. However, the resource costs (i.e., factors such as physician's time, laboratory tests, patient's time away from work) included in...
Autores principales: | Ekwueme, Donatus U, Stroud, Leonardo A, Chen, Yanjing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2099265/ https://www.ncbi.nlm.nih.gov/pubmed/17875244 |
Ejemplares similares
-
Cost-effectiveness of Human Papillomavirus Vaccination in the United States
por: Chesson, Harrell W., et al.
Publicado: (2008) -
Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990–2013
por: Mansfield, Carol, et al.
Publicado: (2016) -
Awareness of breast cancer risk related to a positive family history and alcohol consumption among women aged 15–44 years in United States
por: Khushalani, Jaya S., et al.
Publicado: (2019) -
Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030
por: Gogate, Anagha, et al.
Publicado: (2021) -
Costs of Chronic Diseases at the State Level: The Chronic Disease Cost Calculator
por: Trogdon, Justin G., et al.
Publicado: (2015)